Lisa Boyle

Chief Innovation Officer

Lisa guides our Medical Device CRO team helping clients deliver the next generation of medical devices and in-vitro diagnostics. She has helped MedTech innovators bring to life scores of new medical devices and/or generational enhancements over her 15-plus year career.

Having worked on both sides of the innovator | CRO fence, especially in the coronary and structural heart domains, including senior roles with Medtronic, BD and JenaValve, she understands what innovators need and how to get there be they startups, growth stage companies or large strategics. JenaValve, a pioneer in transcatheter treatment of aortic regurgitation, was acquired by Edwards Life Sciences in 2024.

Lisa brings comprehensive expertise across business unit, corporate, and small business operations, with particular focus on real-world evidence, data analytics, and operational excellence; concept to commercialization and beyond.

Tom Lutzow

Vice President, Research & Design

Meeting an unmet clinical need starts with exceptional design. That’s why Tom Lutzow and his team focus on human factors evaluation, engineering, and testing that drive safer, more effective, and commercially viable solutions. Their work blends user insights with technical excellence—grounded in regulatory foresight and manufacturability—to reduce risk and accelerate development.
Tom has guided hundreds of innovators in shaping novel MedTech concepts into development-ready products. By embedding human-centered design into every phase—and collaborating closely with downstream functions like commercialization—his team ensures the right product gets to market, faster. 

Joe Gordon

Vice President, Innovation and Technology

Based at our Providence, RI Innovation Center, Joe Gordon leads Veranex’s innovation engine—guiding early-stage concepts and generational enhancements into real-world solutions across more than 300 MedTech and in vitro diagnostic (IVD) projects. He specializes in translating ambiguity into actionable strategy, driving clarity through complexity, and aligning multidisciplinary teams to accelerate product realization. Whether it’s digital surgery platforms or wearable drug-delivery devices, Joe ensures each innovation is both breakthrough and buildable.

With over 20 years at the forefront of MedTech development, Joe plays a central role in full lifecycle programs—often leading from nascent idea through commercialization. He excels in navigating crowded patent landscapes and designing robust IP strategies that protect value creation. From capital systems to next-gen diagnostics, Joe’s diverse expertise and strategic foresight help set the innovation direction for clients aiming to reshape healthcare.

Nicolas Borenstein, DVM, MsC, PhD

Senior Vice President, Preclinical Services

Based in our state-of-the-art preclinical facilities in Paris, France, Nicolas Borenstein serves as co-president of preclinical services. He possesses extensive expertise in surgical and transcatheter preclinical science, particularly in cardiovascular medical devices. A widely published author and peer-reviewed journal reviewer, Nicolas combines academic excellence with hands-on surgical expertise. His work and leadership have contributed to hundreds of regulatory submissions for U.S., European and other global regulatory bodies covering the entire range of classifications or complexity from CE mark approvals and U.S. FDA 510ks to Class II and Class III PMA required devices.  His additional qualifications include specialized certifications in microsurgery, experimental surgery, and animal research.